A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)
Recruiting now · Phase 3
Conditions studied: Anemia Due to Chronic Kidney Disease
In brief
This is a Phase III, randomized, open-label, active-controlled study to evaluate the safety and efficacy of AND017 in non-dialysis-dependent (NDD)-CKD patients compared with the active control, ESA treatment
Key facts
- Study ID
- NCT07487727
- Run by
- Kind Pharmaceuticals LLC
- People needed
- 240
- Starts
- 2025-12-03
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2026-03-27
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Peking University People's Hospital — Beijing, Beijing Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.